PD61-05 EARLY POSTOPERATIVE EJACULATORY AND ERECTILE FUNCTION FOLLOWING PHOTOVAPORIZATION OF THE PROSTATE (PVP) AND BIPOLAR PLASMA VAPORIZATION OF THE PROSTATE (BPVP)

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology IV (PD61)1 Apr 2020PD61-05 EARLY POSTOPERATIVE EJACULATORY AND ERECTILE FUNCTION FOLLOWING PHOTOVAPORIZATION OF THE PROSTATE (PVP) AND BIPOLAR PLASMA VAPORIZATION OF THE PROSTATE (BPVP) Lina Posada Calderon*, Mitali Kini, Hudson Pierce, Alexis Te, James A. Kashanian, and Bilal Chightai Lina Posada Calderon*Lina Posada Calderon* More articles by this author , Mitali KiniMitali Kini More articles by this author , Hudson PierceHudson Pierce More articles by this author , Alexis TeAlexis Te More articles by this author , James A. KashanianJames A. Kashanian More articles by this author , and Bilal ChightaiBilal Chightai More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000000978.05AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: GreenLight Photovaporization of the Prostate (PVP) and PlasmaButton bipolar plasma vaporization of the prostate (BPVP) use different energy delivery systems to ablate prostatic tissue in patients with benign prostatic hyperplasia (BPH). Although erectile and ejaculatory dysfunction are an ongoing concern following surgical therapies for BPH, immediate changes and early erectile function following these techniques have not been described. We aimed to describe the erectile changes occurring post-operatively and how they evolve for the first 6 months after surgery. METHODS: Patients with lower urinary tract symptoms (LUTS) secondary to BPH, an International Prostate Symptom Score (IPSS) >12, a prostate volume <80 ml and maximum flow rate (Qmax) <15 ml/s were screened to undergo PVP or BPVP. Male Sexual Health Questionnaire (MSHQ) as well as IPSS and Qmax were assessed preoperatively and at 1, 3 and 6 months postoperatively. Mean values for total MSHQ score as well as for the erection and ejaculation subscales were assessed at each of the time points for each of the procedures. A student’s t-test was performed to compare MSHQ scores at baseline and 6 months post-operatively. RESULTS: A total of 27 patients received PVP (n=13) or BPVP (n=14). Median age was 62.5 (Interquartile range (IQR) 70.3-71.8), median preoperative IPSS 18 (IQR 15.5 – 22), median prostate volume 51.3 (IQR 41-57) and median Qmax 9.4 (IQR 6.1-11.3). Mean baseline MSHQ was 64.6 (standard deviation (SD) 29.5) and mean postoperative measures were 55.7 (SD 32.4), 73.8 (SD 34.4) and 52.7 (SD 44.8) at 1 month, 3 months and 6 months, respectively. The mean change between MSHQ preoperatively and at 6 months was 11.9 points, which was not statistically significant (p=0.166). The change in score for each of the items of the questionnaire is shown in Table 1. Within the PVP group, the mean MSHQ change between baseline and at 6 months was -3.5 (p=0.786) and within the BPVP the mean change was -19.6 (p=0.095). CONCLUSIONS: Early erectile function following prostate ablation with PVP and BPVP drops slightly after the first month but recovers, achieving non-significantly different values compared to baseline. Patients should be counseled on early erectile changes and expectation for the first 6 months after surgery. Source of Funding: None © 2020 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 203Issue Supplement 4April 2020Page: e1281-e1282 Advertisement Copyright & Permissions© 2020 by American Urological Association Education and Research, Inc.MetricsAuthor Information Lina Posada Calderon* More articles by this author Mitali Kini More articles by this author Hudson Pierce More articles by this author Alexis Te More articles by this author James A. Kashanian More articles by this author Bilal Chightai More articles by this author Expand All Advertisement PDF downloadLoading ...